Moderna Starts Application Process for RSV Vaccine

Moderna said on Wednesday it had started the application process to get an approval for its respiratory syncytial virus vaccine in older adults with regulators in the US, Australia, and Europe.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/994009?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost